
Izvēlieties etiķeti
redzama tieši uz flakonaGlow Blend (Mini)
Healing
- Sūtām no Vācijas
Pasūtījums
- DHL ar izsekošanu
- Diskrēts iepakojums
Īsumā
Glow Blend (Mini) skaitļos
Galvenie rādītāji no mūsu leksikona.
Pilns leksikona ieraksts- Class
- Healing/beauty blend
- Use
- Subcutaneousin mg
- Sizes
- 50 mg1 size in the shop
What studies show
All 3 sources in the lexicon- Crockford et al., Annals of the New York Academy of Sciences, 2010
Randomised trial of GHK-Cu gel in diabetic foot ulcers (opens in a new tab)
Mulder et al., Wound Repair and Regeneration, 1994- Malinda et al., Journal of Investigative Dermatology, 1999
Produktam Glow Blend (Mini) vēl nav laboratorijas analīzes. Balsot par toPasūtiet testu, mēs apmaksājam pusiVisas laboratorijas analīzes
Zināšanas
Viss par Glow Blend (Mini)
Detalizēta informācija drīzumā.
Dozēšana
Ielādē dozēšanas informāciju …
Noderēs
Kas jums vēl būs vajadzīgs
Bakteriostatiskais ūdens tiek automātiski pievienots grozam. Šļirces un salvetes - ar vienu klikšķi.
Insulīna šļirces
10 gab. · 5.50 €
Spirta salvetes
50 gab. · 10 €
Cik daudz ūdens?
Vienības uz šļirces jūsu flakona izmēram.
Atvērt kalkulatoru →Are there studies on the Glow Blend?
No. As of 26 October 2026 there is no study on the ready-made blend, neither on ClinicalTrials.gov nor in PubMed. All three compounds together only appear in reviews. The components have been studied, almost always each on its own.
What is the difference from the large Glow Blend?
It is the same mix of BPC-157, TB-500 and GHK-Cu, just in a smaller vial. The evidence is identical for both, since only the single components have been studied.
Is the combination stronger than the single compounds?
That has not been studied. In the only study with two of the three components (tendon healing in rats), BPC-157 plus TB-500 gave no advantage over either compound alone. The authors suspect that both act on shared pathways. There are no data on GHK-Cu in combination.
How well has BPC-157 been studied in humans?
Barely. A systematic review found 36 studies: 35 in animals or cells and one retrospective analysis of 12 people with knee pain. A second review from 2026 counted three small human studies with 30 people in total and rated the evidence as very low.
Is TB-500 the same as thymosin beta-4?
Not quite. TB-500 is described as a fragment of thymosin beta-4. The studies, including the wound healing in rats and the phase 1 trial into a vein, used full thymosin beta-4. We found no study with TB-500 itself.
Which side effects are known?
There are no data for the blend. The three small BPC-157 human studies reported no treatment-related side effects. Thymosin beta-4 was well tolerated in a phase 1 trial into a vein. Solid long-term data are missing for all three. Reviews also warn about contamination from unregulated manufacturing.
Is the Glow Blend approved?
No. Neither the blend nor any of the three components is approved as a medicine (as of October 2026). The least studied are BPC-157 (phase 1 as the highest phase in ChEMBL) and GHK-Cu (only an early phase 1 trial in the registry), which is why phase 1 is shown as the stage here.
Saistītie
Saistītie produkti
BPC-157
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
4 izmēri
Laboratorijā pārbaudīts
= no 5.2 €/flakons
TB-500 (Thymosin B4)
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
3 izmēri
Laboratorijā pārbaudīts
= no 18.8 €/flakons
TB-500 FRAG
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
1 izmērs
= 24.8 €/flakons
BPC + TB Blend
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
3 izmēri
Laboratorijā pārbaudīts
= no 24.8 €/flakons
Glow Blend (Mini)